Bluewillow Biologics

This early-stage trial tests an experimental nasal spray vaccine called BW-1014, designed to protect against pandemic flu. Healthy adults aged 18 to 45 receive two doses of the spray, with or without a nanoemulsion adjuvant, followed by a standard flu shot six months later. Resea…